Scholars@Duke

A Phase 1b Study Evaluating the Safety and Tolerability, and Efficacy of AMG510 in Combination with Everolimus

Clinical Trial Grant
Duke Scholars
Jeffrey Melson Clarke
Principal Investigator Jeffrey Melson Clarke Medicine, Medical Oncology

Awarded By

Amgen, Inc.

Start Date

March 4, 2022

End Date

February 2, 2024
 

Awarded By

Amgen, Inc.

Start Date

March 4, 2022

End Date

February 2, 2024